In the present study, we elucidated that sorafenib-activated CRNDE/ATG4B/autophagy pathway contributed to the reduced sensitivity of sorafenib in HCC cells, which is a novel role of CRNDE to induce sorafenib resistance. This evidence concerns the gene ATG4B and hepatocellular carcinoma.